Endoscopic treatment of primary vesicoureteral reflux

New England Journal of Medicine

Volumn 366, Issue 13, 2012, Pages 1218-1226

  Diamond, David A ^a   Mattoo, Tej K ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; COTRIMOXAZOLE; DEXTRANOMER; HYALURONIC ACID; NITROFURANTOIN; RADIOISOTOPE; SUCCIMER TC 99M;

ACUTE PYELONEPHRITIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BEHAVIOR THERAPY; BLADDER DYSFUNCTION; CASE REPORT; CHILD; CYSTOGRAPHY; CYSTOURETHROGRAPHY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENDOSCOPIC THERAPY; FEEDBACK SYSTEM; FEMALE; FLANK PAIN; GENERAL ANESTHESIA; HEMATURIA; HUMAN; HYDRONEPHROSIS; KIDNEY FAILURE; KIDNEY SCAR; KIDNEY SCINTISCANNING; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; REFLUX NEPHROPATHY; RENOVASCULAR HYPERTENSION; SCHOOL CHILD; URETER REIMPLANTATION; URINARY TRACT INFECTION; VESICOURETERAL REFLUX; VOMITING;

EID: 84859051383     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMct1108922     Document Type: Article

References (58)

1. Lebowitz RL. The detection and characterization of vesicoureteral reflux in the child. J Urol 1992;148:1640-2.
2. Sargent MA. What isthe normal prevalence of vesicoureteral reflux? Pediatr Radiol 2000;30:587-93.
3. Venhola M, Hannula A, Huttunen NP, et al. Occurrence of vesicoureteral reflux in children. Acta Paediatr 2010;99:1875-8.
4. Wu CY, Chiu PC, Hsieh KS, Chiu CL, Shih CH, Chiou YH. Childhood urinary tract infection: a clinical analysis of 597 cases. Acta Paediatr Taiwan 2004;45:328-33.
5. Chand DH, Rhoades T, Poe SA, Kraus S, Strife CF. Incidence and severity of vesicoureteral reflux in children related to age, gender, race and diagnosis. J Urol 2003; 170:1548-50. (Pubitemid 37102405)
6. Skoog SJ, Belman AB. Primary vesicoureteral reflux in the black child. Pediatrics 1991;87:538-43.
7. Schwab CW Jr, Wu HY, Selman H, Smith GH, Snyder HM 3rd, Canning DA. Spontaneous resolution of vesicoureteral reflux: a 15-year perspective. J Urol 2002; 168:2594-9. (Pubitemid 35402698)
8. Birmingham Reflux Study Group. Prospective trial of operative versus nonoperative treatment of severe vesicoureteric reflux in children: five years' observation. Br Med J (Clin Res Ed) 1987;295: 237-41.
9. Tamminen-Möbius T, Brunier E, Ebel KD, et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment: the International Reflux Study in Children. J Urol 1992;148:1662-6.
10. Cooper CS. Diagnosis and management of vesicoureteral reflux in children. Nat Rev Urol 2009;6:481-9.
11. Schwentner C, Oswald J, Lunacek A, et al. Health-related quality of life in children with vesicoureteral reflux - impact of successful endoscopic therapy. J Pediatr Urol 2008;4:20-6.
12. Peters CA, Skoog SJ, Arant BS Jr, et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol 2010;184:1134-44.
13. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 2010; 126:1084-91.
14. Mattoo TK. Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis 2011;5:348-54.
15. Paquin AJ Jr. Ureterovesical anastomosis: the description and evaluation of a technique. J Urol 1959;82:573-83.
16. Radmayr C, Schwentner C, Lunacek A, Karatzas A, Oswald J. Embryology and anatomy of the vesicoureteric junction with special reference to the etiology of vesicoureteral reflux. Ther Adv Urol 2009; 1:243-50.
17. Tanagho EA, Guthrie TH, Lyon RP. The intravesical ureter inprimary reflux. J Urol 1969;101:824-32.
18. Khoury A, Bagli DG. Reflux and megaureter. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders, 2007:3423-81.
19. Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE. International system of radiographic grading of vesicoureteric reflux: International Reflux Study in Children. Pediatr Radiol 1985;15:105-9. (Pubitemid 15198933)
20. Ransley PG, Risdon RA. Reflux nephropathy: effects of antimicrobial therapy on the evolution of the early pyelonephritic scar. Kidney Int 1981;20:733-42. (Pubitemid 12169009)
21. Swerkersson S, Jodal U, Sixt R, Stokland E, Hansson S. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children. J Urol 2007;178:647-51. (Pubitemid 47030521)
22. Cotran RS. Glomerulosclerosis inreflux nephropathy. Kidney Int 1982;21:528- 34.
23. Politano VA, Leadbetter WF. An operative technique for the correction of vesicoureteral reflux. J Urol 1958;79:932-41.
24. Stenberg A, Läckgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and shortterm clinical results. J Urol 1995;154:800-3.
25. Holmdahl G, Brandström P, Läckgren G, et al. The Swedish reflux trial in children: II. vesicoureteral reflux outcome. J Urol 2010;184:280-5.
26. Brandström P, Esbjörner E, Herthelius M, Swerkersson S, Jodal U, Hansson S. The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol 2010; 184:286-91.
27. Brandström P, Nevéus T, Sixt R, Stokland E, Jodal U, Hansson S. The Swedish reflux trial in children: IV. Renal damage. J Urol 2010;184:292-7.
28. Capozza N, Caione P. Dextranomer/ hyaluronic acid copolymer implantation for vesico-ureteral reflux: a randomized comparison with antibiotic prophylaxis. J Pediatr 2002;140:230-4. (Pubitemid 34183664)
29. Routh JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics 2010;125:1010-9.
30. Alon US, Hoberman A, Dairiki Shortliffe LM. Treatment of a6-year-old girl with vesicoureteral reflux. N Engl J Med 2011;365:266-70.
31. Lorenzo AJ. Medical versus surgical management for vesicoureteric reflux: the case for medical management. Can Urol Assoc J 2010;4:276-8.
32. Khalil BA, Goyal A, Dickson AP. Surgical intervention inchildren with vesicoureteric reflux: are we intervening too late? Pediatr Surg Int 2010;26:729-31.
33. Higham-Kessler J, Reinert SE, Snodgrass WT, et al. A review of failures of endoscopic treatment of vesicoureteral reflux with dextranomer microspheres. J Urol 2007;177:710-4.
34. Capozza N, Lais A, Matarazzo E, Nappo S, Patricolo M, Caione P. Influence of voiding dysfunction on the outcome of endoscopic treatment for vesicoureteral reflux. J Urol 2002;168:1695-8. (Pubitemid 35034057)
35. Traxel E, DeFoor W, Reddy P, Sheldon C, Minevich E. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection. J Urol 2009;182: Suppl:1708-12.
36. Puri P, O'Donnell B. Correction of experimentally produced vesicoureteric reflux in the piglet by intravesical injection of Teflon. Br Med J (Clin Res Ed) 1984; 289:5-7. (Pubitemid 14085311)
37. Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC. The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 2004;171:2413-6. (Pubitemid 38625504)
38. Puri P, Chertin B, Velayudham M, Dass L, Colhoun E. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/ hyaluronic acid copolymer: preliminary results. J Urol 2003;170:1541-4. (Pubitemid 37102403)
39. Dave S, Lorenzo AJ, Khoury AE, et al. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer. J Urol 2008;180:Suppl:1594- 9.
40. Gupta A, Snodgrass W. Intra-orifice versus hydrodistention implantation technique in dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 2008;180:Suppl:1589-92.
41. Elder JS, Diaz M, Caldamone AA, et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis: I. Reflux resolution and urinary tract infection. J Urol 2006; 175:716-22. (Pubitemid 43067431)
42. Kobelt G, Canning DA, Hensle TW, Läckgren G. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2003;169:1480-4. (Pubitemid 36323822)
43. Saperston K, Smith J, Putman S, et al. Endoscopic subureteral injection isnot less expensive than outpatient open reimplantation for unilateral vesicoureteral reflux. J Urol 2008;180:Suppl:1626-9.
44. Sorensen MD, Koyle MA, Cowan CA, Zamilpa I, Shnorhavorian M, Lendvay TS. Injection volumes of dextranomer/hyaluronic acid are increasing in the endoscopic management of vesicoureteral reflux. Pediatr Surg Int 2010;26:509-13.
45. Läckgren G, Wáhlin N, Sköldenberg E, Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2001;166:1887-92. (Pubitemid 32953451)
46. Capozza N, Lais A, Nappo S, Caione P. The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience. J Urol 2004;172:1626-8.
47. Vandersteen DR, Routh JC, Kirsch AJ, et al. Postoperative ureteral obstruction after subureteral injection of dextranomer/ hyaluronic acid copolymer. J Urol 2006; 176:1593-5. (Pubitemid 44307247)
48. Snodgrass WT. Obstruction of adysmorphic ureter following dextranomer/ hyaluronic acid copolymer. J Urol 2004; 171:395-6. (Pubitemid 37549195)
49. Cerwinka WH, Kaye JD, Scherz HC, Kirsch AJ, Grattan-Smith JD. Radiologic features of implants after endoscopic treatment of vesicoureteral reflux in children. AJR Am J Roentgenol 2010;195:234-40.
50. Nelson CP, Chow JS. Dextranomer/ hyaluronic acid copolymer (Deflux) implants mimicking distal ureteral calculi on CT. Pediatr Radiol 2008;38:104-6. (Pubitemid 350164907)
51. Noe HN. Calcification in aDeflux bleb thought to be a ureteral calculus in a child. J Pediatr Urol 2008;4:88-9.
52. Lorenzo AJ, Pippi Salle JL, Barroso U, et al. What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years. J Urol 2006;176:1851-5. (Pubitemid 44291711)
53. Yucel S, Gupta A, Snodgrass W. Multi- variate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 2007;177:1505-9. (Pubitemid 46435990)
54. Krill AJ, Pohl HG, Belman AB, et al. Parental preferences in the management of vesicoureteral reflux. J Urol 2011;186: 2040-4.
55. Lee EK, Gatti JM, Demarco RT, Murphy JP. Long-term followup of dextranomer/ hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup. J Urol 2009;181:1869-74.
56. Diamond DA, Caldamone AA, Bauer SB, Retik AB. Mechanisms of failure of endoscopic treatment of vesicoureteral reflux based on endoscopic anatomy. J Urol 2003;170:1556-8.
57. Kalisvaart JF, Scherz HC, Cuda S, Kaye JD, Kirsch AJ. Intermediate tolongterm follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesico-ureteral reflux. J Pediatr Urol 2011 August 3 (Epub ahead of print).
58. National Institute for Health and Clinical Excellence. Urinary tract infection in children (CG54). August 2007 (http://www.nice.org.uk/CG54).